Clinical images: Osseous and subcutaneous tophus

The therapeutic effect of tumor necrosis factor (TNF)inhibition is certainly well recognized from studies usinganti-TNF monoclonal antibodies and soluble TNF receptorfusion proteins. The article by Maini et al (Maini RN, Breed-veld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, et al.Therapeutic...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:: 2001

Institución:: Universidad del Rosario

Repositorio:: Repositorio EdocUR - U. Rosario

Idioma:: eng

id	EDOCUR2_beb64cd5077ba05ebbf246bcf36b4c1c
oai_identifier_str	oai:repository.urosario.edu.co:10336/27377
network_acronym_str	EDOCUR2
network_name_str	Repositorio EdocUR - U. Rosario
repository_id_str
spelling	19474778600967d5ab8-ed72-4c03-ba99-04b36bdc1582-12020-08-19T14:41:57Z2020-08-19T14:41:57Z2001-04-26The therapeutic effect of tumor necrosis factor (TNF)inhibition is certainly well recognized from studies usinganti-TNF monoclonal antibodies and soluble TNF receptorfusion proteins. The article by Maini et al (Maini RN, Breed-veld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, et al.Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factoramonoclonal antibody combined withlow-dose weekly methotrexate in rheumatoid arthritis. Arthri-tis Rheum 1998;41:1552–63.) provides further evidence thatTNF inhibition improves signs and symptoms of rheumatoidarthritis (RA). Unfortunately, some of the statements made inthe article are either invalid or not supportable.application/pdfhttps://doi.org/10.1002/1529-0131(199908)42:8<1783::AID-ANR37>3.0.CO;2-TISSN: 0004-3591EISSN: 1529-0131https://repository.urosario.edu.co/handle/10336/27377engJohn Wiley & Sons1784No. 81783Arthritis & RheumatismVol. 42Arthritis & Rheumatism, ISSN: 0004-3591;EISSN: 1529-0131, Vol.42, No.8 (August, 1999); pp.1783-1784https://onlinelibrary.wiley.com/doi/10.1002/1529-0131(199908)42:8%3C1783::AID-ANR37%3E3.0.CO;2-TAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2Arthritis & Rheumatisminstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURMonoclonal antiphospholipid antibodiesClinical images: Osseous and subcutaneous tophusImágenes clínicas: tofo óseo y subcutáneoarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Anaya, Juan-ManuelDelgado, Jorge10336/27377oai:repository.urosario.edu.co:10336/273772022-05-02 07:37:21.903966https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv	Clinical images: Osseous and subcutaneous tophus
dc.title.TranslatedTitle.spa.fl_str_mv	Imágenes clínicas: tofo óseo y subcutáneo
title	Clinical images: Osseous and subcutaneous tophus
spellingShingle	Clinical images: Osseous and subcutaneous tophus Monoclonal antiphospholipid antibodies
title_short	Clinical images: Osseous and subcutaneous tophus
title_full	Clinical images: Osseous and subcutaneous tophus
title_fullStr	Clinical images: Osseous and subcutaneous tophus
title_full_unstemmed	Clinical images: Osseous and subcutaneous tophus
title_sort	Clinical images: Osseous and subcutaneous tophus
dc.subject.keyword.spa.fl_str_mv	Monoclonal antiphospholipid antibodies
topic	Monoclonal antiphospholipid antibodies
description	The therapeutic effect of tumor necrosis factor (TNF)inhibition is certainly well recognized from studies usinganti-TNF monoclonal antibodies and soluble TNF receptorfusion proteins. The article by Maini et al (Maini RN, Breed-veld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, et al.Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factoramonoclonal antibody combined withlow-dose weekly methotrexate in rheumatoid arthritis. Arthri-tis Rheum 1998;41:1552–63.) provides further evidence thatTNF inhibition improves signs and symptoms of rheumatoidarthritis (RA). Unfortunately, some of the statements made inthe article are either invalid or not supportable.
publishDate	2001
dc.date.created.spa.fl_str_mv	2001-04-26
dc.date.accessioned.none.fl_str_mv	2020-08-19T14:41:57Z
dc.date.available.none.fl_str_mv	2020-08-19T14:41:57Z
dc.type.eng.fl_str_mv	article
dc.type.coarversion.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv	Artículo
dc.identifier.doi.none.fl_str_mv	https://doi.org/10.1002/1529-0131(199908)42:8<1783::AID-ANR37>3.0.CO;2-T
dc.identifier.issn.none.fl_str_mv	ISSN: 0004-3591 EISSN: 1529-0131
dc.identifier.uri.none.fl_str_mv	https://repository.urosario.edu.co/handle/10336/27377
url	https://doi.org/10.1002/1529-0131(199908)42:8<1783::AID-ANR37>3.0.CO;2-T https://repository.urosario.edu.co/handle/10336/27377
identifier_str_mv	ISSN: 0004-3591 EISSN: 1529-0131
dc.language.iso.spa.fl_str_mv	eng
language	eng
dc.relation.citationEndPage.none.fl_str_mv	1784
dc.relation.citationIssue.none.fl_str_mv	No. 8
dc.relation.citationStartPage.none.fl_str_mv	1783
dc.relation.citationTitle.none.fl_str_mv	Arthritis & Rheumatism
dc.relation.citationVolume.none.fl_str_mv	Vol. 42
dc.relation.ispartof.spa.fl_str_mv	Arthritis & Rheumatism, ISSN: 0004-3591;EISSN: 1529-0131, Vol.42, No.8 (August, 1999); pp.1783-1784
dc.relation.uri.spa.fl_str_mv	https://onlinelibrary.wiley.com/doi/10.1002/1529-0131(199908)42:8%3C1783::AID-ANR37%3E3.0.CO;2-T
dc.rights.coar.fl_str_mv	http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv	Abierto (Texto Completo)
rights_invalid_str_mv	Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	John Wiley & Sons
dc.source.spa.fl_str_mv	Arthritis & Rheumatism
institution	Universidad del Rosario
dc.source.instname.none.fl_str_mv	instname:Universidad del Rosario
dc.source.reponame.none.fl_str_mv	reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv	Repositorio institucional EdocUR
repository.mail.fl_str_mv	edocur@urosario.edu.co
_version_	1808390905231572992

Clinical images: Osseous and subcutaneous tophus

Publicaciones similares